Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study,”1 published online December 19, 2018, and in the February print issue of JAMA Psychiatry, there was an error in a 95% CI in the Results section of the abstract and the text. The 95% CI for the effect size for the insomnia score should be −0.61 to −0.02, not −0.65 to 0.02. The article has been corrected online.
Error in Results Sections. JAMA Psychiatry. 2019;76(2):219. doi:10.1001/jamapsychiatry.2019.0067
Coronavirus Resource Center